iShares Genomics Immunology and Healthcare ETF Rating $24.89 +0.36 (+1.47%) Closing price 10/24/2025 04:10 PM EasternExtended Trading$24.70 -0.19 (-0.76%) As of 10/24/2025 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock iShares Genomics Immunology and Healthcare ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IDNA Aggregate RatingModerate Buy 2.59Holdings in IDNA have an aggregate rating of Moderate Buy based on 248 analyst ratings issued in the past year covering 17 companies (54.1% of the portfolio).IDNA Aggregate Price Target$24.89High Prediction$24.89Average Prediction$24.89Low Prediction$24.89Holdings in IDNA have an aggregate price target of $24.89 and a range of $24.89 to $24.89 covering 17 companies (54.1% of the portfolio).IDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy11 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Genomics Immunology and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 17 IDNA Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.61%ACLXArcellx$84.68+0.7%2.6548 of 5 stars2.86$113.08 33.5%14News CoveragePositive NewsAnalyst Forecast4.41%INCYIncyte$91.28+2.2%4.4848 of 5 stars2.32$84.79 -7.1%19Upcoming EarningsAnalyst Forecast4.14%RVMDRevolution Medicines$54.48+1.9%4.3241 of 5 stars3.00$77.50 42.3%16Analyst Forecast4.06%REGNRegeneron Pharmaceuticals$577.95+0.4%4.8843 of 5 stars2.79$802.35 38.8%28Positive NewsUpcoming EarningsAnalyst Forecast3.89%MRKMerck & Co., Inc.$87.54+0.4%4.9964 of 5 stars2.30$104.33 19.2%20Positive NewsUpcoming EarningsAnalyst Forecast3.69%TWSTTwist Bioscience$34.11+7.2%4.0023 of 5 stars2.64$48.56 42.3%11Analyst ForecastGap Up3.61%MRNAModerna$26.74+1.9%4.1833 of 5 stars2.00$36.86 37.8%21Trending NewsAnalyst ForecastAnalyst Revision3.48%BNTXBioNTech$105.66+0.9%2.5779 of 5 stars2.64$133.96 26.8%14News CoverageAnalyst Forecast3.19%EXELExelixis$38.72+1.8%4.7582 of 5 stars2.64$44.53 15.0%25Analyst UpgradeAnalyst Revision3.07%CELCCelcuity$70.97+0.6%1.8441 of 5 stars2.67$65.50 -7.7%6Analyst ForecastAnalyst Revision2.77%ABCLAbCellera Biologics$5.66-0.9%2.4212 of 5 stars2.71$8.00 41.3%7Analyst ForecastGap Up2.64%NVAXNovavax$8.52+1.9%4.592 of 5 stars2.00$11.33 33.0%9Trending NewsAnalyst ForecastAnalyst RevisionGap Up2.41%JANXJanux Therapeutics$24.90+1.8%1.9722 of 5 stars2.94$79.08 217.6%16News CoverageAnalyst Forecast2.34%BCRXBioCryst Pharmaceuticals$7.20+0.1%4.3098 of 5 stars2.77$19.18 166.4%13Analyst Forecast2.16%IMNMImmunome$15.69-2.3%1.7262 of 5 stars2.82$23.20 47.9%11News CoverageAnalyst Forecast1.93%RCUSArcus Biosciences$17.32+3.2%2.7657 of 5 stars2.60$27.22 57.2%10Analyst Forecast1.67%GERNGeron$1.24+1.6%2.7926 of 5 stars2.13$3.79 205.3%8News CoverageGap Up This page (NYSEARCA:IDNA) was last updated on 10/25/2025 by MarketBeat.com Staff From Our PartnersIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | Sponsored$4,200 gold is nice ... but here’s what most gold bugs are missingGold just surged past $4,200, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Genomics Immunology and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Genomics Immunology and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
